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Conﬂicting pieces of evidence have been reported on the role of TG2 in apoptosis. In this report, we
showed that TG2 increased in response to low level of oxidative stress, whereas TG2 diminished
under high stress conditions. Monitoring TG2 expression, activity and calcium concentration in cells
treated with A23187 revealed that the initial rise of calcium activates TG2 but subsequent calcium-
overload induces degradation of TG2 via calcium-mediated polyubiquitination. These results indicate
that the role of TG2 in apoptosis depends on the level of calcium inﬂux triggered by oxidative stress.
Structured summary:
MINT-6824687: TG2 (uniprotkb:P21980) physically interacts (MI:0218) with Ubiquitin (uniprotkb:P62988)
by anti bait coimmunoprecipitation (MI:0006)
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Transglutaminase 2 (TG2) is a calcium-dependent enzyme that
catalyzes transamidation reaction that produces cross-linked pro-
teins [1]. TG2-mediated reaction is irreversible and cross-linked
protein products are resistant to proteolytic degradation. Thus, it
was recognized that TG2 is involved in cell adhesion, extracellular
matrix formation, and apoptosis [2].
The cells undergoing apoptosis were reported to show an in-
crease of TG2 activity [3]. TG2 was thought to be responsible in
cross-linking proteins to membrane in order to prevent the cellular
leakage, which is a main characteristic of apoptosis [4]. However,
TG2-deﬁcient mice showed no evidence of diminished apoptosis
[5]. Moreover, it was reported that the TG2 expression of the cancer
cells, selected for doxorubicin-resistance, was up-regulated [6], andchemical Societies. Published by E
ltra violet; BP, biotinylated
hydrogenase; HA, hemagglu-
eptavidinthe down-regulation of the TG2 expression by siRNA sensitizes the
cancer cell to doxorubicin [7]. They seem to exhibit the anti-apop-
totic function of TG2 under oxidatively stressed conditions. These
apparently conﬂicting evidences on the role of TG2 in apoptosis
suggest that TG2might be regulated in different manner depending
upon the various type or relative strength of oxidative stresses.
Intracellular TG2 is inactive under normal culture conditions,
and activated through oxidative stress-induced calcium inﬂux by
a treatment with H2O2 or UV irradiation [8,9]. Calcium-binding
activates transamidation activity of TG2 which is inhibited by
GTP binding [10]. Calcium-bound TG2 has a wide open structure
when compared with that of GDP-bound TG2 [11,12]. Recently, it
has been reported that calcium-bound TG2 is more vulnerable to
proteolysis by trypsin or l-calpain than inactive TG2 due to con-
formational changes [13], suggesting that activated TG2 is sub-
jected to proteolytic degradation. On the other hand, another
report showed that caspase-3 is responsible for degradation of
TG2 in calcium-induced apoptosis [14]. Therefore, mechanism for
the degradation of TG2 in the cells undergoing apoptosis has not
been clearly elucidated.
In this study, we examined the level of TG2 protein in HeLa cells
exposed to various type of oxidative stress with different strength,
and found that TG2 protein diminished only when cells were
exposed to a high level of oxidative stress. The decrease in TG2lsevier B.V. All rights reserved.
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ubiquitination. These results suggest that the intracellular calcium
concentration determines the role of TG2 in cells under oxidatively
stressed conditions.
2. Materials and methods
2.1. Cell culture
HeLa and SK-N-SH cells were cultured in Dulbecco’s modiﬁed
Eagle’s medium (DMEM) supplemented with 10% fetal bovine
serum (Hyclone), 100 U/ml of penicillin, 100 lg/ml of streptomy-
cin sulfate, and 2 mM glutamine. To investigate the effect of oxida-
tive stress on the expression of TG2, the cells were exposed to UVC
(UVC-508, ULTRA-LUM Inc.; 50, 200, and 800 J/m2, respectively), or
treated with either H2O2 (1 and 3 mM, respectively), doxorubicin
(50 and 800 ng/ml, respectively), or A23187 (Calbiochem; 5, 10,
20, and 30 lM, respectively) for indicated period of time and main-
tained in culture medium until analysis.
Cell death of HeLa cells was estimated by ﬂow cytometric anal-
ysis of sub-G0/G1 population. After exposure to oxidative stress,
cells were ﬁxed in ice-cold 70% ethanol for 24 h at 4 C. The cells
were resuspended and incubated in propodium iodide staining
solution (phosphate-buffered saline containing 50 lg/ml PI
(Sigma) and 0.1 mg/ml RNase A) for 30 min at 37 C, and then ana-Fig. 1. Effect of oxidative stress on Transglutaminase 2 (TG2) expression. (A) Western blo
free media and cultured in DMEM containing 10% FBS (top). HeLa cells were exposed to
incubated for 3 and 7 days. (B) HeLa cells were exposed to 50 J/m2 UV, and incubated for
primers designed to amplify the TG2 and GAPDH transcripts (top). The PCR products w
evaluated based on the electrophoresis data and presented at the bottom. (C) Wester
doxorubicin. (D) Flow cytometric analysis of HeLa cells after propodium iodide staininglyzed by FACScalibur with CellQuest software (ver3.3, BD
Biosciences).
2.2. Reverse transcription–polymerase chain reaction (RT-PCR)
Total RNA was extracted from cultured cells using TRIzol re-
agent (Invitrogen). The RNA was then employed in the ﬁrst-strand
cDNA synthesis reactions using oligo (dT) primer (Promega) and
SuperScript II reverse transcriptase (Invitrogen). The human TG2
was ampliﬁed using primers (forward 50-TAAGAGATGCTGTGGAG-
GAG-30 and reverse 50-CGAGCCCTGGTAGATAAA-30). The thermocy-
cling conditions were 1 cycle (95 C, 10 min), 18 cycles (94 C, 30 s;
55 C, 30 s; 72 C, 1 min 30 s), 10 cycles (94 C, 30 s; 55 C, 30 s;
72 C, 1 min 30 s with autoextension for 5 s per cycle) and ﬁnal
extension at 72 C for 10 min. GAPDH was ampliﬁed using primers
(forward 50-ACCACAGTCCATGCCATCAC-30 and reverse 50-TCCAC-
CACCCTGTTGCGTA-30). PCR products were analyzed by 1% agarose
gel electrophoresis, followed by staining with ethidium bromide.
2.3. Intracellular TG2 activity assay
Intracellular TG2 activity was assayed as described previously
[8]. In short, cells were incubated with 1 mM biotinylated pentyl-
amine (BP, Pierce) for 30 min at 37 C before harvesting. Cell
extracts were prepared by disrupting the cells in lysis buffert analysis of the cell extracts of HeLa cells treated with 1 mM H2O2 for 1 h in serum
50 J/m2 UV (bottom, left) or treated with 50 ng/ml doxorubicin (bottom, right), and
1, 3 and 6 days. Total RNA was isolated and RT-PCR reactions were performed using
ere analyzed by 1% agarose gel electrophoresis. TG2/GAPDH for each sample was
n blot analysis of HeLa cells treated with 3 mM H2O2, 200 J/m2 UV, or 800 ng/ml
under oxidatively stressed conditions.
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X-100, and protease inhibitor cocktail, Roche) followed by
centrifugation (12000g) for 10 min at 4 C. For microtiter plate
assay, the cell extract (0.2 mg/ml, 50 ll/well) was added to each
well of a 96-well microtiter plate (Nunc). After incubating with
horseradish peroxidase-conjugated streptavidin (Zymed) for 1 h,
TG2 activity was quantiﬁed by the reaction with o-phenylenedi-
amine dihydrochloride (Sigma) and measuring absorbance at
490 nm on microplate spectrophotometer (Molecular Devices).
For Western blot analysis, the cell extracts were subjected to
SDS–PAGE using 10% gel and then transferred to nitrocellulose
membrane. The proteins that crosslink with BP were visualized
by probing with HRP-conjugated streptavidin, followed by en-
hanced chemiluminescence reagents (Pierce).
2.4. Measurement of intracellular calcium concentration
Intracellular calcium concentration, [Ca2+]i, was measured using
Fluo-4AM (Molecular Probes), as described previously [9]. Brieﬂy,
3  104 cells were cultured for 12 h in a 96-well microplate. After
exposing cells to UVC, the cells were incubated for 30 min at 37 C
in 100 ll of assay buffer (Han’s Balanced Salt Solution in 20 mMFig. 2. Effect of low and high stress on the intracellular [Ca2+] and TG2 of HeLa cells. (A)
measured by ﬂuorescence intensity. The results are presented in (fold), using the ﬂuoresc
extract, monitoring TG2 level after exposure to UV irradiation. (C) Western blot analys
response to UV irradiation. (D) Monitoring intracellular TG2 activity evaluated by solid-p
the cells harvested at zero time. (E) Intracellular TG2 activity visualized by Western blo
Cells were exposed to UV irradiation and harvested after 4 h. NT; not treated. SA-HRP; hor
standard deviations based on three experiments.HEPES, pH 7.4) containing 5 lM Fluo-4AM and incubated further
for 30 min at room temperature. After washing with assay buffer
four times, the ﬂuorescence intensity was measured (excitation at
494 nm and emission at 516 nm). Cells were then stained with
0.04%CrystalViolet in4% (v/v) ethanol tonormalize theﬂuorescence
value.
2.5. Preparation of adenovirus to overexpress TG2
The recombinant adenoviral plasmids were generated by
homologous recombination in Escherichia coli, according to the
manufacturer’s instructions (Qbiogene, Inc.). In brief, pAdTrack,
shuttle vector, was used to generate GFP-trackable viruses contain-
ing TG2. To produce adenoviruses in mammalian cells, HEK293
cells were transfected with recombinant adenoviral DNA which
was prepared by PacI digestion, followed by ethanol precipitation.
The transfected cells were monitored for GFP expression and col-
lected after 7–10 days by centrifugation. After three cycles of freez-
ing in liquid nitrogen and rapid thawing at 37 C, 1 ml of the lysate
was used to infect HEK293 cells in 15 cm2 culture dish. Three to
four days later, viruses were harvested and evaluated for TG2
expression in SK-N-SH cells.Monitoring of intracellular [Ca2+] level of HeLa cells after exposure to UV irradiation
ence intensity of not-irradiated cells as control. (B) Western blot analysis of cellular
is of cellular extract to test the effect of BAPTA-AM or EGTA on TG2 expression in
hase microtiter plate assay. TG2 activity was expressed as a relative value to that of
t analysis in the presence or absence of either EGTA (5 mM) or BAPTA-AM (10 lM).
seradish peroxidase-conjugated streptavidin. The ﬁgure shows the mean values and
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HeLa cells (1.5  106) were cultured in a 10 cm2 dish for 18 h at
37 C and transfected with 16 lg of DNA (pMT123HA-ubiquitin)
using Lipofectamine (Invitrogen). After incubating for 36 h, the
cells were treated with 3 mM H2O2 in serum free media for 4 h
or exposed to UV irradiation (2 kJ/m2) and additionally incubated
for 2 h. Separately, HeLa cells were pretreated with 50 lM
MG132 for 1 h and additionally treated with 10 lM A23187 for
4 h. The cells were washed with Dulbecco’s Phosphate-Buffered
Saline (140 mM NaCl, 2.6 mM KCl, 10 mM Na2HPO4, 1.8 mM
KH2PO4) two times and lysed with binding buffer (50 mM Tris–
Cl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, protease
inhibitor cocktail), followed by centrifugation (12000g, 10 min
at 4 C). TG2 in cell lysate was isolated by immunoprecipitation
method as follows. The cell lysate was pre-cleared with protein
A-agarose (Pierce) for 1 h, and then incubated with anti-TG2 anti-
body-conjugated protein A-agarose overnight at 4 C. Beads were
washed four times with binding buffer at 4 C, and the bound pro-
teins were eluted from beads by boiling for 10 min in sampling
buffer (12 mM Tris–Cl, pH 6.8, 5% glycerol, 0.4% SDS, 0.4% 2-
mercaptoethanol, 0.02% bromophenol blue). The eluted proteins
were analyzed by western blot method using anti-HA antibody.
2.7. Western blot analysis
Cell lysate was prepared using lysis buffer (50 mM Tris–Cl, pH
7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, and protease
inhibitor cocktail) as described earlier. The cellular proteins were
extracted by sonication, followed by centrifugation (12,000g,Fig. 3. Dose-response effect of A23187 on the intracellular [Ca2+] and TG2 of HeLa cells
A23187, respectively. (B) Western blot analysis of the cells monitoring the effect of variou
TG2 activity of HeLa cells after treatment with various concentration of A23187, measu10 min at 4 C). After estimating the protein concentration of
supernatant using BCA Protein Assay Reagent (Pierce, Rockford,
IL, USA), the cellular proteins (10–30 lg) were resolved by PAGE
using 6–12% gel and transferred to nitrocellulose membrane. The
proteins were probed with monoclonal antibodies speciﬁc for
TG2 [15], b-actin (Santa Cruz), or HA (Roche Applied Biosciences),
followed by enhanced chemiluminescence detection (ECL, Pierce).
3. Results
3.1. Regulation of TG2 expression responding to the different level of
oxidative stress
Conﬂicting evidences have been reported on the role of TG2 in
apoptosis under various stress conditions [4]. To test as to the ability
of cells to induce the TG2 expression in response to different type of
stress, we monitored the level of TG2 expression in HeLa cells after
treatment with 1 mM H2O2 (Fig. 1A, top). Western blot analysis of
cell lysates showed that TG2 expression increased gradually up to
8 days. We then examined the effect of UV irradiation or doxorubi-
cin treatment on the TG2 expression. The treatment of the cells with
either 50 ng/ml doxorubicin or 50 J/m2 UV irradiation produced a
similar induction of TG2 expression (Fig. 1A, bottom). We next
determine if a low level of oxidative stress regulates TG2 expression
at the transcriptional level. Semi-quantitative RT-PCR analysis
showed that the transcript level of TG2 in the cells exposed to
50 J/m2 UV irradiation increased gradually up to 3 days and de-
creased thereafter (Fig. 1B). However, when the cells were treated
with high level of stress, such as 3 mM H2O2, 200 J/m2 UV, or
800 ng/ml doxorubicin, the protein level of TG2 diminished in all. (A) Monitoring the intracellular [Ca2+] of HeLa cells treated with 5 lM and 20 lM
s A23187 concentrations on the TG2 level of HeLa cells. (C) Monitoring intracellular
red by solid-phase microtiter plate assay.
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matedby sub-G0/G1population,was observedduring the sameper-
iod under the same conditions (Fig. 1D). In the case of doxorubicin
treatment, apoptotic cells were appeared in sub-G2/M population.
3.2. Calcium-dependent TG2 degradation
Oxidative stress induces an increase of calcium inﬂux which
activates intracellular TG2 as well as calcium-dependent proteo-
lytic enzymes [9]. To test whether elevated calcium concentration
is responsible for the decrease of TG2 protein, we examined the
cytosolic calcium concentration ([Ca2+]i) under oxidative stress
conditions. When HeLa cells were exposed to 800 J/m2 of UV irra-
diation, [Ca2+]i increased 2-fold after 3 h, and reached a peak of 5-
fold after 13 h. However, a low dose UV irradiation (50 J/m2) did
not produce any signiﬁcant change in [Ca2+]i during the same per-
iod of time (Fig. 2A). Western blot analysis showed that the protein
level of TG2 diminished after 2 h of 800 J/m2 UV irradiation,
whereas no signiﬁcant change of TG2 protein was observable with
50 J/m2 UV irradiation (Fig. 2B). To establish the causal relation-
ship, HeLa cells were cultured in the medium that contains
10 lM BAPTA-AM or 10 mM EGTA and then exposed to UV irradi-
ation. Western blot analysis revealed that the depletion of calcium
in the medium abrogated the UV-induced diminution of TG2 pro-
tein (Fig. 2C). Since an elevation of [Ca2+]i can activate TG2 enzyme,Fig. 4. Polyubiquitination of TG2 by oxidative stresses. (A, B) Western blot analysis of
additionally treated with 10 lM A23187 for 4 h (A) or exposed to 800 J/m2 UV irradiation
containing TG2. After a pretreatment with 50 lM MG132 for 1 h, cells were treated wit
were transfected with pMT123HA-ubiquitin and then exposed to 2 kJ/m2 UV (D, left) or tr
and probed in Western blot analysis with anti-HA antibody. Ubiquitinated TG2 isolated i
10 lM A23187 for 4 h (E). (Ub)n-TG2, polyubiquitinated TG2; WB, western blot.wemonitored intracellular TG2 activity. After exposure to 800 J/m2
UV, the TG2 activity rapidly rose to a maximum after 4 h and de-
clined thereafter (Fig. 2D). When the effect of EGTA and BAPTA-
AM on intracellular TG2 activity was compared, EGTA was found
to abrogate the UV-induced TG2 activation more effectively than
BAPTA-AM, indicating that extracellular calcium may be responsi-
ble for TG2 activation (Fig. 2E). It appears that in HeLa cells, ex-
posed to 50 J/m2 UV, intracellular TG2 activity correlated with
neither [Ca2+]i nor TG2 expression level.
To conﬁrm these observations further, we treated HeLa cells
with A23187 at various concentrations. [Ca2+]i increased progres-
sively with time in 5 or 20 lM A23187 and reached a maximum le-
vel to 3.5- or 8.2-fold after 2 h, respectively (Fig. 3A) as previously
reported [16]. Western blot analysis for TG2 showed that the treat-
ment with A23187 diminished TG2 protein level with increasing
A23187 concentration. It was previously demonstrated that HeLa
cells exposed to 20 or 30 lM A23187 undergo apoptosis as indi-
cated by reduced b-actin [17–19]. Our experiments clearly show
that the TG2 diminished rapidly under these conditions (Fig. 3B).
The treatment of the cells with 5 or 10 lM A23187 raised intracel-
lular TG2 activity within 1 h and maintained the same level after-
ward. In contrast, the treatment of the cells with 20 or 30 lM
A23187 raised TG2 activity in less than 1 h and then dropped con-
trol value (Fig. 3C), probably due to the calcium-dependent degra-
dation of TG2 molecules.TG2 in the cell extracts of HeLa cells pretreated with 50 lM MG132 for 1 h and
(B). (C) Monitoring the over-expressed TG2 in SK-N-SH cells infected by adenovirus
h 10 lM A23187. (D, E) Polyubiquitination of TG2 by oxidative stresses. HeLa cells
eated with 3 mM H2O2 (D, right). TG2 was isolated by immunoprecipitation method
n the HeLa cells pretreated with 50 lMMG132 for 1 h and additionally treated with
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via ubiquitination
Previously, it was reported that TG2 is an in situ substrate of l-
calpain [20]. In this study, we examined the breakdown product(s)
of intracellular TG2 by l-calpain following either a treatment with
10 lM A23187 or an exposure to 800 J/m2 UV. However, Western
blot analysis failed to detect any breakdown product of TG2. When
50 lM MG132, proteasomal inhibitor, was added to HeLa cells, in
addition to A23187, the protein level of TG2 was restored to the
native level, indicating that a decrease of TG2 by oxidative stress
might be due to proteasomal degradation (Fig. 4A and B). We con-
ﬁrmed these observations using SK-N-SH cells which overexpress
TG2 (Fig. 4C). To verify the proteasomal degradation of TG2, HeLa
cells transfected with pMT123HA-ubiquitin were treated with
3 mM H2O2 or exposed to 2 kJ/m2 UV irradiation, and TG2 in the
cell lysates was immunoprecipitated with anti-TG2 antibody-pro-
tein A-agarose. Western blot analysis showed that the ubiquitina-
tion of TG2 was increased in response to high level of oxidative
stresses (Fig. 4D). In addition, the pretreatment of HeLa cells with
50 lM MG132 inhibited the degradation of ubiquitinated TG2 in-
duced by A23187 treatment (Fig. 4E).4. Discussion
TG2 was presumed to play a pro-apoptotic function based on
the increase in its activity in cells undergoing apoptosis [3]. How-
ever, recent studies showed that TG2 may also protect cells from
apoptosis that is induced by various cytotoxic agents such as reti-
namide and doxorubicin [21,22]. In this study, we found that while
a low level of oxidative stress on HeLa cells induces TG2 expres-
sion, a high level of oxidative stress triggers a degradation of intra-
cellular TG2 through Ca2+-mediated ubiquitination. The cellular
response to low or high level of stress was monitored in term of
intracellular TG2 activity and Ca2+ concentration. The results
showed that an increase in [Ca2+]i initially activates TG2, but under
a high stress condition the excess [Ca2+]i induces the degradation
of TG2 leading to apoptosis. It seems, therefore, that the level of
intracellular calcium is a major factor that determines the role of
TG2 in cellular apoptosis.
Since TG2 catalyzes the modiﬁcation of substrate molecules
that are resistant to proteolysis, the sustained activity of TG2
in response to oxidative stress may produce the aggregation of
protein molecules [23]. Presumably, the intracellular TG2 activity
is delicately regulated to avoid molecular aggregation. It was re-
ported that l-calpain and caspase-3 degrade intracellular TG2
causing the inactivation of TG2 [14,20]. However, a recent study
showed that intracellular TG2 in l-calpain-null erythrocytes was
degraded by treatment with ionomycin even in the presence of
caspase-3 inhibitor [24]. Our ﬁnding is consistent with this re-
port, that is, intracellular TG2 is degraded through ubiquitina-
tion. Several proteins are also known to be degraded by
calcium-mediated ubiquitination. In Mammalian eggs, sperm-de-
rived calcium activates anaphase promoting complex (APC), an
ubiquitin E3 ligase, that triggers anaphase onset by targeting cy-
clin A, cyclin B and securin for destruction [25]. Islet-brain 1/JNK
interacting protein 1 (IB1/JIP1) in pancreatic b-cells is degraded
by increased intracellular calcium by treatment of cytokine or
A23187 [26]. Additionally, the treatment of HeLa cells with
A23187 was reported to polyubiquitinate TRE17/USP6 oncogene
[27]. Thus, the ubiquitination of TG2 may be a critical factor to
regulate TG2 activity which, in turn, determines cellular apopto-
sis. However, the ubiquitination of TG2 was reported to be re-
lated to the activation of TG2 in the absence of IFNc or
retinoic acid [28]. Therefore, identiﬁcation of E3 ligase for TG2ubiquitination is needed to understand the role of TG2 in the
stress response.
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